 |
Astex Pharmaceuticals to Present at UBS Global Healthcare Conference
May 14, 2013
|
11.3 KB |
|
| |
DUBLIN, Calif., May 14, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that James S.J. Manuso, PhD, chairman and chief executive officer, will present at the 2013 UBS Global Healthcare Conference on Monday M...
|
|
Astex Pharmaceuticals Reports 2013 First Quarter Financial Results
Apr 29, 2013
|
24.8 KB |
|
| |
Data reported at AACR on several preclinical and clinical programs Ends quarter with $137 million in cash & marketable securities First quarter royalty revenue increases 7.3% to $22.1 million
DUBLIN, Calif., April 29, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX) today announced financial results for the first quarter ended...
|
|
Astex Pharmaceuticals to Present at Needham Healthcare Conference
Apr 23, 2013
|
11.3 KB |
|
| |
DUBLIN, Calif., April 23, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that James S.J. Manuso, PhD, chairman and chief executive officer, will present at the Needham 12th Annual Healthcare Conference on Tu...
|
|
Astex Pharmaceuticals to Announce 2013 First Quarter Financial Results on April 29th
Apr 22, 2013
|
11.6 KB |
|
| |
DUBLIN, Calif., April 22, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that it will release its 2013 first quarter results on Monday, April 29, 2013. James S.J. Manuso, PhD, chairman and chief executive of...
|
|
Astex Pharmaceuticals Provides SGI-110 Update
Apr 10, 2013
|
24.4 KB |
|
| |
Oral Presentation at AACR Supports Potential of SGI-110 In The Treatment Of Platinum-Resistant Ovarian Cancer
Clinical Update on SGI-110-01 Study
DUBLIN, Calif., April 10, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule t...
|
|
Astex Pharmaceuticals Pipeline Data Presentations at AACR
Apr 3, 2013
|
13.3 KB |
|
| |
DUBLIN, Calif., April 3, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced the acceptance of thirteen abstracts covering internal and partner funded pipeline product data for poster or oral presentation at the ...
|
|
Astex Pharmaceuticals to Present at ROTH Conference
Mar 12, 2013
|
11.7 KB |
|
| |
DUBLIN, Calif., March 12, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that James S.J. Manuso, PhD, chairman and chief executive officer, will present at the 25th Annual ROTH Conference on Tuesday March 19...
|
|
Astex Pharmaceuticals Reports 2012 Fourth Quarter and Year-End Financial Results
Feb 25, 2013
|
28.2 KB |
|
| |
Reports Annual Net Income of $8.2 MillionDacogen Royalty Revenue Increases 17.5% from Prior Year Ends Year with $138 Million in Cash & Marketable Securities
DUBLIN, Calif., Feb. 25, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), today reported financial results for the fourth quarter and year ended December 31, 2012.
Th...
|
|
Astex Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference
Feb 20, 2013
|
11.7 KB |
|
| |
DUBLIN, Calif., Feb. 20, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that Mohammad Azab, MD, chief medical officer, and Michael Molkentin, chief financial officer, will present at the 2013 RBC Capital Mar...
|
|
Astex Pharmaceuticals to Announce 2012 Fourth Quarter and Year-End Financial Results on February 25th
Feb 19, 2013
|
12.2 KB |
|
| |
DUBLIN, Calif., Feb. 19, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that it will release its 2012 fourth quarter and fiscal year-end results on Monday, February 25, 2013. James S.J. Manuso, PhD, chairman...
|
|
Astex Pharmaceuticals to Present at BIO CEO & Investor Conference
Feb 5, 2013
|
11.7 KB |
|
| |
DUBLIN, Calif., Feb. 5, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that James S.J. Manuso, PhD, chairman and chief executive officer, will present at the 15th Annual BIO CEO & Investor Conference on Tues...
|
|
Cancer Research UK and Cancer Research Technology Initiate AT13148 Clinical Trial to Treat Several Cancer Types
Jan 16, 2013
|
17.8 KB |
|
| |
DUBLIN, Calif., Jan. 16, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that collaborators Cancer Research UK and its commercial arm Cancer Research Technology (CRT) are launching a trial of an experimental ...
|
|
Astex Pharmaceuticals to Present at Biotech Showcase 2013
Jan 3, 2013
|
11.8 KB |
|
| |
DUBLIN, Calif., Jan. 3, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that James S.J. Manuso, PhD, chairman and chief executive officer, will present at Biotech Showcase 2013 on Wednesday, January 9th in Sa...
|
|
Astex Pharmaceuticals Announces Initiation of SGI-110 Phase 2 Trial in Advanced Hepatocellular Carcinoma (HCC) Patients
Jan 2, 2013
|
16.6 KB |
|
| |
DUBLIN, Calif., Jan. 2, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, announced that it has initiated a Phase 2, open-label, single-arm, non-randomized clinical trial, evaluating SGI-110 in the treatment of advanced hepato...
|
|
Astex Pharmaceuticals Announces Results From Dose Escalation Part of SGI-110 Phase 1/2 MDS and AML Study in an Oral Presentation at ASH
Dec 10, 2012
|
16.0 KB |
|
| |
DUBLIN, Calif., Dec. 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, announced encouraging Phase I clinical results during a presentation at the American Society of Hematology (ASH) of SGI-110, a novel second generation ...
|
|
Astex Pharmaceuticals to Present at Oppenheimer Healthcare Conference
Dec 5, 2012
|
11.9 KB |
|
| |
DUBLIN, Calif., Dec. 5, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that James S.J. Manuso, PhD, chairman and chief executive officer, and Harren Jhoti, PhD, president and director, will present at the Op...
|
|
Astex Pharmaceuticals Announces December 14th Analyst and Investor Day Agenda
Dec 4, 2012
|
13.3 KB |
|
| |
DUBLIN, Calif., Dec. 4, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced the agenda for its Analyst and Investor Day webcast, to take place from 10 am to 12:15 pm GMT on Friday, December 14th in London, UK.
...
|
|
Astex Pharmaceuticals Announces Oral Presentation of SGI-110 Results From Phase 1/2 MDS and AML Study at ASH
Nov 20, 2012
|
16.0 KB |
|
| |
DUBLIN, Calif., Nov. 20, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, announced that results from the dose escalation part of a randomized Phase 1/2 first-in-human clinical trial of subcutaneous SGI-110, a novel hypomethy...
|
|
Astex Pharmaceuticals to Present at Lazard Healthcare Conference
Nov 7, 2012
|
11.8 KB |
|
| |
DUBLIN, Calif., Nov. 7, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that James S.J. Manuso, PhD, chairman and chief executive officer, and Mohammad Azab, MD, chief medical officer, will present at the Laz...
|
|
Astex Pharmaceuticals to Present at EORTC-NCI-AACR
Oct 31, 2012
|
12.8 KB |
|
| |
DUBLIN, Calif., Oct. 31, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced the acceptance of three abstracts for presentation at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics. Poster...
|
|
|
Delicious
Digg
Facebook
LinkedIn
Twitter